NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Food and Microbiome Longitudinal Investigation (FAMiLI)

Recruiting

Conditions: Cancer
Cardiovascular Diseases

First Posted Date: 2017-09-26

Last Posted Date: 2025-04-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 14000

Registration Number: NCT03293758

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Sleep Aging and Risk for Alzheimer's 2.0

Active, not recruiting

Conditions: Sleep Apnea
Alzheimer Disease

Interventions: Diagnostic Test: PET Scan and nocturnal polysomnography

First Posted Date: 2017-09-11

Last Posted Date: 2025-05-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 158

Registration Number: NCT03278119

Locations: 🇺🇸
Healthy Brain Aging and Sleep Center, New York, New York, United States

Immune Checkpoint Therapy With Nivolumab Esophageal Squamous Cell Carcinoma

Phase 1

Terminated

Conditions: Esophageal Squamous Cell Carcinoma

Interventions: Drug: Nivolimumab+Carboplatin/paclitaxel+Radiation

First Posted Date: 2017-09-11

Last Posted Date: 2022-03-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 12

Registration Number: NCT03278626

Locations: 🇺🇸
University of Califonia, San Diego, La Jolla, California, United States
🇺🇸
University of Southern California, Los Angeles, California, United States
🇺🇸
New York University School of Medicine, New York, New York, United States

and more 2 locations

A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion

Phase 2

Completed

Conditions: Spinal Fusion

Interventions: Drug: Saline
Drug: Ketamine

First Posted Date: 2017-09-07

Last Posted Date: 2018-06-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 129

Registration Number: NCT03274453

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

Phase 1

Terminated

Conditions: Alzheimer Disease

Interventions: Drug: Escitalopram Pill
Drug: Venlafaxine Pill
Drug: Placebo Oral Tablet

First Posted Date: 2017-09-07

Last Posted Date: 2020-06-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 5

Registration Number: NCT03274817

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

High-intensity Group Vocal Exercise to Improve Laryngeal Function in Patients With Parkinson Disease

Not Applicable

Completed

Conditions: Parkinson Disease

Interventions: Behavioral: Choral (group) singing therapy sessions

First Posted Date: 2017-08-28

Last Posted Date: 2018-08-27

Lead Sponsor: NYU Langone Health

Target Recruit Count: 18

Registration Number: NCT03263793

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Dementia Symptom Management at Home Program

Not Applicable

Completed

Conditions: Dementia

Interventions: Behavioral: DSM-H
Behavioral: Standard of Care

First Posted Date: 2017-08-21

Last Posted Date: 2024-01-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 217

Registration Number: NCT03255967

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Geography of ED Use and Population Health

Completed

Conditions: Emergencies
Diabetes Mellitus

Interventions: Other: Statewide Planning and Research Cooperative System Database

First Posted Date: 2017-08-18

Last Posted Date: 2021-02-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT03254524

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Turmeric as Treatment in Epilepsy

Not Applicable

Withdrawn

Conditions: Focal Seizures
Epilepsy
Lennox-Gastaut Syndrome
Dravet Syndrome
Tuberous Sclerosis

Interventions: Dietary Supplement: Turmeric

First Posted Date: 2017-08-18

Last Posted Date: 2018-04-30

Lead Sponsor: NYU Langone Health

Registration Number: NCT03254680

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Effects of Cannabidiol in Alcohol Use Disorder

Phase 1

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Phytocannabinoid cannabidiol (CBD)
Other: Placebo

First Posted Date: 2017-08-17

Last Posted Date: 2023-05-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 27

Registration Number: NCT03252756

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy